384 related articles for article (PubMed ID: 21318055)
1. AMPK as Target for Intervention in Childhood and Adolescent Obesity.
Rojas J; Arraiz N; Aguirre M; Velasco M; Bermúdez V
J Obes; 2011; 2011():252817. PubMed ID: 21318055
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and improvements in signal transduction.
Musi N; Goodyear LJ
Endocrine; 2006 Feb; 29(1):73-80. PubMed ID: 16622294
[TBL] [Abstract][Full Text] [Related]
4. Adenosine monophosphate-activated protein kinase is elevated in human cachectic muscle and prevents cancer-induced metabolic dysfunction in mice.
Raun SH; Ali MS; Han X; Henríquez-Olguín C; Pham TCP; Meneses-Valdés R; Knudsen JR; Willemsen ACH; Larsen S; Jensen TE; Langen R; Sylow L
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1631-1647. PubMed ID: 37194385
[TBL] [Abstract][Full Text] [Related]
5. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
[TBL] [Abstract][Full Text] [Related]
6. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.
Viollet B; Mounier R; Leclerc J; Yazigi A; Foretz M; Andreelli F
Diabetes Metab; 2007 Dec; 33(6):395-402. PubMed ID: 17997341
[TBL] [Abstract][Full Text] [Related]
7.
Lee HA; Cho JH; Afinanisa Q; An GH; Han JG; Kang HJ; Choi SH; Seong HA
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33142995
[No Abstract] [Full Text] [Related]
8. AMPK in Health and Disease.
Steinberg GR; Kemp BE
Physiol Rev; 2009 Jul; 89(3):1025-78. PubMed ID: 19584320
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
10. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
[TBL] [Abstract][Full Text] [Related]
11. Offspring body size and metabolic profile - effects of lifestyle intervention in obese pregnant women.
Tanvig M
Dan Med J; 2014 Jul; 61(7):B4893. PubMed ID: 25123127
[TBL] [Abstract][Full Text] [Related]
12. [Metformin and AMPK: an old drug and a new enzyme in the context of metabolic syndrome].
Santomauro Júnior AC; Ugolini MR; Santomauro AT; Souto RP
Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):120-5. PubMed ID: 18345405
[TBL] [Abstract][Full Text] [Related]
13. Post-Translational Modifications of the Energy Guardian AMP-Activated Protein Kinase.
Ovens AJ; Scott JW; Langendorf CG; Kemp BE; Oakhill JS; Smiles WJ
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513781
[TBL] [Abstract][Full Text] [Related]
14. Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice.
Kim D; Lee JE; Jung YJ; Lee AS; Lee S; Park SK; Kim SH; Park BH; Kim W; Kang KP
Int J Mol Med; 2013 Dec; 32(6):1293-302. PubMed ID: 24068196
[TBL] [Abstract][Full Text] [Related]
15. The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity.
Steinberg GR; Jørgensen SB
Mini Rev Med Chem; 2007 May; 7(5):519-26. PubMed ID: 17504187
[TBL] [Abstract][Full Text] [Related]
16. Metformin mitigates renal dysfunction in obese insulin-resistant rats via activation of the AMPK/PPARα pathway.
Thongnak L; Pengrattanachot N; Promsan S; Phengpol N; Sutthasupha P; Jaikumkao K; Lungkaphin A
Arch Pharm Res; 2023 May; 46(5):408-422. PubMed ID: 36966452
[TBL] [Abstract][Full Text] [Related]
17. Combination of Metformin and Exercise in Management of Metabolic Abnormalities Observed in Type 2 Diabetes Mellitus.
Jevtovic F
Diabetes Metab Syndr Obes; 2021; 14():4043-4057. PubMed ID: 34557007
[TBL] [Abstract][Full Text] [Related]
18. AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity.
O'Neill HM; Holloway GP; Steinberg GR
Mol Cell Endocrinol; 2013 Feb; 366(2):135-51. PubMed ID: 22750049
[TBL] [Abstract][Full Text] [Related]
19. AMP activated protein kinase: a next generation target for total metabolic control.
Misra P
Expert Opin Ther Targets; 2008 Jan; 12(1):91-100. PubMed ID: 18076373
[TBL] [Abstract][Full Text] [Related]
20. AMP-activated protein kinase in metabolic control and insulin signaling.
Towler MC; Hardie DG
Circ Res; 2007 Feb; 100(3):328-41. PubMed ID: 17307971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
